Recruiting
Phase 1
Phase 2

MRG004A

Sponsor:

Shanghai Miracogen Inc.

Code:

NCT04843709

Conditions

Advanced or Metastatic Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MRG004A

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-03. This information was provided to ClinicalTrials.gov by Shanghai Miracogen Inc. on 2022-09-08.